Simon Zhornitsky, Ph.D.
Affiliations: | 2012 | Université de Montréal, Montréal, Canada |
Area:
Clinical Psychology, Mental HealthGoogle:
"Simon Zhornitsky"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Stephane Potvin | grad student | 2012 | Université de Montréal | |
| (Psychiatric and neurological symptoms in schizophrenia and substance use disorder patients treated for 12-weeks with quetiapine.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhornitsky S, Tourjman V, Pelletier J, et al. (2022) Acute effects of ketamine and esketamine on cognition in healthy subjects: A meta-analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 118: 110575 |
| Zhornitsky S, Chaudhary S, Le TM, et al. (2021) Cognitive dysfunction and cerebral volumetric deficits in individuals with Alzheimer's disease, alcohol use disorder, and dual diagnosis. Psychiatry Research. Neuroimaging. 317: 111380 |
| Le TM, Potvin S, Zhornitsky S, et al. (2021) Distinct patterns of prefrontal cortical disengagement during inhibitory control in addiction: A meta-analysis based on population characteristics. Neuroscience and Biobehavioral Reviews. 127: 255-269 |
| Zhornitsky S, Pelletier J, Assaf R, et al. (2020) Acute effects of partial CB receptor agonists on cognition - A meta-analysis of human studies. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110063 |
| Zhornitsky S, Le TM, Dhingra I, et al. (2020) Interpersonal Risk Factors for Suicide in Cocaine Dependence: Association with Self-Esteem, Personality Traits, and Childhood Abuse. Suicide & Life-Threatening Behavior. e12621 |
| Zhornitsky S, Tikàsz A, Rizkallah É, et al. (2015) Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis. Journal of Addiction. 2015: 843762 |
| Potvin S, Zhornitsky S, Stip E. (2015) Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 60: S26-34 |
| Stip E, Vincent PD, Sablier J, et al. (2013) A randomized controlled trial with a Canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia. Frontiers in Pharmacology. 4: 100 |
| Zhornitsky S, Wee Yong V, Koch MW, et al. (2013) Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair. Cns Neuroscience & Therapeutics. 19: 737-44 |
| Zhornitsky S, Aubin G, Desfossés J, et al. (2013) Predictors of community functioning in schizophrenia and substance use disorder patients. Community Mental Health Journal. 49: 317-22 |